HDL antioxidant effects as assessed using a nonexchangeable probe to monitor particle-specific peroxidative stress in LDL-HDL mixtures.

Tribble, Diane L.; Chu, Berbie M.; Gong, Enhao; Venrooij, Francine V. van; Nichols, Alex V.

doi:10.1016/s0022-2275(20)41094-6

Cited by 27 publications

(1 citation statement)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Efficacy assessment made on the basis of the primary outcome and secondary outcome. [17,18] [Table 2].…”

Section: Efficacy Assessmentmentioning

confidence: 99%

Untitled

2022

IJGP

View full text Add to dashboard Cite

Background: Metabolic syndrome is a cluster of risk factors for CVD and diabetes. The number of individuals with metabolic syndrome continues to rise. The current study aimed to test the efficacy and safety of an Integrative Unani personalized regimen (IUPR) in reducing the risk factors of metabolic syndrome. Materials and Methods: Patients according to NCEP ATP III criteria were selected, 50 patients (30 in the test group and 20 in the control group) completed the study. The test group was treated with an IUPR and the control group was treated for respective risk factors with standard drugs for 2 months. The response was measured by changes in TC, TG, HDL, FBS, BP, WC, and Weight. Results: IUPR was found superior in reducing body weight, waist circumference, and BP (P < 0.01), equivalent in reducing serum triglyceride and fasting blood sugar level and inferior in reducing total cholesterol compared to standard drugs provided for respective risk factors after 2 months of intervention. HDL increased by 1.033 mg/dl in the test and decreased in the control group by 4.850 mg/dl. Conclusion: In metabolic syndrome lipid storage increases due to the deterrence of the pathological mechanisms. Unani regimen caused a reduction in risk factors of the metabolic syndrome might be by attenuation in physiological changes possibly by reverting rate-limiting enzymes and increasing energy expenditure. Long-term high-quality trials with dietary modification are needed to get optimal results.

show abstract

“…Efficacy assessment made on the basis of the primary outcome and secondary outcome. [17,18] [Table 2].…”

Section: Efficacy Assessmentmentioning

confidence: 99%